SGTX

Here's Why Sigilon Therapeutics Stock Is Tanking Today

Why Galectin Is Soaring And Sigilon Is Sinking Today

Serious Adverse Event Triggers FDA Clinical Hold On Sigilon Therapeutics' Hemophilia A Trial, Shares Drop

Sigilon Therapeutics Stock Falls Over 20% Pre-Market: Why It Happened

Sigilon Therapeutics Announces Clinical Hold on SIG-001 Phase 1/2 Study in Hemophilia A

Biotech Losers In 2021 That Could Bounce Big In The Second Half

Sigilon Therapeutics Appoints Brooke Story, M.B.A., to its Board of Directors